MEDICAL RESEARCH SUPPORT LLC - THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.

PIID: 75N95A26P00038

Signed Date: Feb 6, 2026Effective Date: Feb 6, 2026End Date: Closes in 145 days

Award $

$21K

Vendor

MEDICAL RESEARCH SUPPORT LLC

NAICS

518210

Signed Date

Feb 6, 2026

Key Details

Dollars Obligated

$21,450

Base & All Options

$21,450

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

National Institutes of Health

NAICS Code

518210 - COMPUTING INFRASTRUCTURE PROVIDERS, DATA PROCESSING, WEB HOSTING, AND RELATED SERVICES

Product Service Code

B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA

Extent Competed

COMPETED UNDER SAP

Number of Offers

Place of Performance

GAITHERSBURG, MD, 208780003, CD-MD-06

Description

THIS IS SERVICE FOR PHASE 1/PHASE 2 OPEN LABEL TRIAL OF A NOVEL INDENOISOQUINOLONE CMYC/TOPOISOMERASE 1 INHIBITOR (LMP744) IN RECURRENT GLIOBLASTOMA. POP: 02/06/2026 TO 02/05/2027.

Context & Analysis

On Feb 6, 2026, Department of Health and Human Services obligated $21,450 to MEDICAL RESEARCH SUPPORT LLC for this is service for phase 1/phase 2 open label trial of a novel indenoisoquinolone cmyc/topoisomerase 1 inhibitor (lmp744) in recurrent glioblastoma. pop: 02/06/2026 to 02/05/2027.. The award is classified under NAICS 518210 — COMPUTING INFRASTRUCTURE PROVIDERS, DATA PROCESSING, WEB HOSTING, AND RELATED SERVICES and issued as a firm fixed price contract. Competition extent: competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in GAITHERSBURG, MD. The contract is scheduled through Feb 5, 2027 — approximately 5 months remaining.